Selenium Supplementation Decreases Crp and Il-6 and Increases Tnf-Alpha: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Publisher Pubmed



Gholizadeh M¹ ; Khalili A² ; Roodi PB³ ; Saeedy SAG⁴ ; Najafi S⁵ ; Keshavarz Mohammadian M⁶ ; Djafarian K⁷
Source: Journal of Trace Elements in Medicine and Biology Published:2023

Abstract

Inflammation is an initiating cause of infectious and non-infectious diseases. Studies have shown that selenium (Se) has anti-inflammatory effects. However, its’ effects on serum c-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) plasma concentrations are equivocal. Therefore, we performed a systematic review and meta-analysis of randomized controlled trials (RCTs), evaluating the effects of per oral (PO) and intravenous (IV) Se supplementation on CRP, TNF-α, and IL-6. A systematic search was conducted using four databases, including PubMed, Google Scholar, Cochrane Library, and Scopus to find randomized clinical trials, published up to April 2023. From 19476 papers, after screening and removing duplicate articles, 24 studies were analyzed in the present meta-analysis. In the pooled analysis, PO Se administration showed no significant effect on CRP (WMD: 0.12; 95 % CI −0.11, 0.38; P-value= 0.30). However, IV Se supplementation had a significant negative association with CRP concentration (−2.24; 95 % CI: −4.24, −0.24; p-value: 0.02). Se administration had no significant association with TNF-α plasma concentration (9.64, 95 % CI: −0.59, 19.88, p-value= 0.06; and heterogeneity: 98 %). However, a significant positive association was present between Se and plasma TNF-α concentrations (0.15, 95 % CI: 0.14, 0.17, P-value<0.0001). Moreover, Se supplementation had a significant negative correlation with IL-6 plasma concentration in PO (−0.54; 95 % CI: −1.61, 0.52; P-value = 0.31) and IV administrations (−4.77; 95 % CI: −7.61, −1.93; P-value<0.0001), respectively. This study demonstrated that IV Se administration reduced CRP and IL-6 plasma concentrations. Conversely, IV Se supplementation increased TNF-α plasma concentration. It is evident that further, well-controlled clinical trials are required. © 2023 Elsevier GmbH